(16.BETA.)-21-(ACETYLOXY)-2'-METHYL-5'H-PREGNA-1,4-DIENO(17,16-D)OXAZOLE-3,11,20-TRIONE
UNII 7WCA3Z2SCX
Substance Identification & Data
This profile provides standardized clinical and technical data for (16.beta.)-21-(acetyloxy)-2'-methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,11,20-trione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7WCA3Z2SCX.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 13649-84-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H29NO6 VJUGFCDBNUADOZ-NEFXMTTNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (16.beta.)-21-(acetyloxy)-2'-methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,11,20-trione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.